- Mevaldi closed a funding round with HTGF and ICIG Ventures to scale its technology.
- The investment supports the production of bio-based 3MPD for sustainable applications.
- Mevaldi aims to transition from pilot to demonstration scale with this funding.
- The production chain is entirely within Europe, using ICIG's plant capacities.
Funding and Partners
Mevaldi B.V., a Dutch biotech company, has secured funding from High-Tech Gründerfonds (HTGF) and ICIG Ventures. This investment will enable Mevaldi to scale up its technology for producing bio-based chemical building blocks.
Innovative Technology
Since its founding in 2020, Mevaldi has developed 3MPD, a bio-based building block for high-performance applications in coatings, adhesives, and elastomers. This product is made from renewable raw materials using a patented hybrid bio-thermocatalytic process.
Production and Impact
The production of 3MPD occurs entirely within Europe, utilizing ICIG's existing plant capacities. This approach reduces environmental impact and supports the EU's goals for a circular economy and strategic autonomy.
Future Plans
The funding will help Mevaldi transition from pilot to demonstration scale and focus on commercializing its flagship product, Pentonext®, for sustainable polyesters and polyurethanes.
